MGC Diagnostics (MGCD) Reports Q2 EPS of $0.10

MGC Diagnostics (NASDAQ: MGCD) reported Q2 EPS of $0.10, versus $0.02 reported last year. Revenue for the quarter came in at $9.4 million, versus $8.7 million reported last year.

For earnings history and earnings-related data on MGC Diagnostics (MGCD) click here.

You May Also Be Interested In

• JPMorgan Upgrades Aviva Plc (AV/:LN) (AIVAF) to Overweight
• Epsilon Energy Ltd. (EPSN) Reports Q2 EPS of $0.23
• Logistic Properties of the Americas (LPA) Reports Q2 results